They should question Kennedy directly about his views on forcibly relicensing patents — and upending America's entire ...
Democrats responded to Donald Trump's repeal of Biden executive orders aimed at lowering prescription drug prices and ...
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...
Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...
The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily ...
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...
The companies took issue with the agency’s latest findings, contending that their practices reduce drug costs. “Optum is lowering the cost of specialty medications, which comprises half of all ...
Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than ... pipeline is the most diversified in the company's recent history, with its portfolio is broadening ...
Advanced Micro Devices is investing $20 million in Absci, a drug-discovery company based in Washington state, in a move aimed at selling its artificial intelligence chips in the healthcare sector.
Indian pharmaceutical companies are projected to achieve a revenue growth of 9-11% in FY25. This growth is expected to be fueled by robust performances in key markets, including the United States, ...
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes. By Brendan Borrell When Stephane Castel first ...